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Abstract
Hand, foot and mouth disease (HFMD) and herpangina (HA) are frequently caused by several distinct serotypes belonging to the human
enterovirus A species (HEVA). Enterovirus 71 is considered as a signiﬁcant public health threat because of rare but fatal neurological
complications. A sentinel surveillance system involving paediatricians from Clermont-Ferrand (France) was set up to determine the clini-
cal and epidemiological characteristics of HFMD/HA associated with enterovirus infections. A standardized report form was used to col-
lect demographic and clinical data. Throat or buccal specimens were obtained prospectively and tested for the presence of
enteroviruses. The frequency of HEVA serotypes was determined by genotyping. Phylogenetic relationships were analysed to identify
potential new virus variants. From 1 April to 31 December 2010, a total of 222 children were enrolled. The predominant clinical pre-
sentation was HA (63.8%) and this was frequently associated with clinical signs of HFMD (48%). An enterovirus infection was diagnosed
in 143 (64.4%) patients and serotype identiﬁcation was achieved in 141/143 (98.6%). The predominant serotypes were coxsackievirus
A10 (39.9%) and A6 (28%), followed by coxsackievirus A16 (17.5%) and enterovirus 71 (6.3%). Fever was observed in 115 (80.4%) chil-
dren. No patient had neurological complications. Coxsackievirus A10 and A6 strains involved in the outbreak were consistently geneti-
cally related with those detected earlier in Finland and constituted distinct European lineages. Although several enterovirus serotypes
have been involved in HFMD/HA cases, the outbreak described in this population survey was caused by coxsackievirus A6 and coxsac-
kievirus A10, the third dual outbreak in Europe in the last 3 years.
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Introduction
Hand, foot and mouth disease (HFMD) is a common child-
hood disorder that typically presents as a brief, febrile illness
characterized by the association of oral ulcerations (enanthe-
ma) and vesicular rash (exanthema) on the palms, soles and/
or buttocks. In herpangina (HA), the enanthema resembles
that in HFMD except that the ulcerative lesions are predom-
inantly located on the posterior oropharyngeal structures
[1].
Human enteroviruses (HEVs) are the aetiological agents
involved in most cases of both HFMD and HA, in particular
the serotypes belonging to the A species (HEVA), a group of
22 genetically related serotypes [2]. Two serotypes, coxsac-
kievirus A16 (CV-A16) and enterovirus 71 (EV-71), cause
most of the epidemics worldwide [3–5]. Epidemiological
studies of HFMD/HA outbreaks in Europe, Southeast Asia
and North America showed that CV-A16 and a number of
other HEVA serotypes usually cause self-limiting infections
[6–10]. In contrast, during outbreaks involving EV-71, neurological
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complications (acute ﬂaccid paralysis, brainstem encephalitis
associated with cardiopulmonary oedema) may occur. In a
prospective study of HFMD epidemics in Sarawak, Malaysia
over 7 years, 10–30% of children with HFMD manifestations
caused by EV-71 developed central nervous system complica-
tions of which brainstem encephalitis (58%) was the most
frequent presentation, for review see [11]. Since 1997, epi-
demic waves of EV-71 infections have swept countries in the
Asia Paciﬁc region [6]. Circulating EV-71 strains are clustered
in genogroups B and C, and in sub-genogroups B0–B5 and
C1–C5 [12–14], and changes in the predominant sub-geno-
group are observed at each epidemic wave [6].
In Europe, outbreaks of EV-71 neurological infections with
high case fatality rates were recorded in the 1970s [15,16].
In recent years, EV-71 genogroups C1 and C2 virus strains
have been detected in several countries and an increased
incidence of infections was observed in 2007 [14,17,18].
Infections resulting in fatal outcome have also been reported
[19]. There is a need for reinforced surveillance of HFMD/
HA in children and rapid diagnosis to differentiate benign
HEVA serotypes from EV-71.
We set up a citywide sentinel surveillance system of
HFMD/HA, involving a university paediatric emergency unit
and paediatricians in private practice. We performed a pro-
spective observational study to assess the relative frequency
of HEVA infections, to identify the different associated sero-
types, and to establish well-deﬁned procedures for future
survey studies at a national level.
Patients and Methods
Patients and data collection
From 1 April to 31 December 2010, sentinel paediatricians
were requested to collect clinical specimens from patients
presenting with HFMD, HA or gingivostomatitis. Informed
consent was obtained from each child’s accompanying par-
ent.
Throat or buccal swabs (when oral ulcerations were pres-
ent) were collected using a universal viral transport system
(Becton Dickinson, Sparks, MD, USA). Each specimen along
with a standardized report form was prospectively sent to
the virology laboratory for detection of the EV genome,
genotyping and viral culture. The form recorded information
on the patient’s demographics and clinical ﬁndings. Ten clini-
cal manifestations (fever, vesicular rash of palms, soles or
other localization, oral ulcers, gingivostomatitis, HA, diges-
tive/respiratory/ear nose and throat/neurological signs) were
recorded. Fever was a rectal temperature higher than 38C.
HFMD was deﬁned as oral ulcers on the tongue and buccal
mucosa with vesicular rash on the hands, feet, knees or but-
tocks. HA was deﬁned as oral ulceration affecting predomi-
nantly the anterior tonsillar pillars, soft palate, or the uvula.
Gingivostomatitis was deﬁned as oral ulcers on the buccal
and gingival mucosa. Neurological manifestations were
deﬁned as clinical signs of meningitis, encephalitis or convul-
sions. Environmental data (contact with persons presenting
similar symptoms, child-care arrangements) were also
recorded on the form. Results of viral testing were sent
prospectively to the physicians with an extra copy for the
patient. Sentinel paediatricians were informed monthly of
the results of the prospective surveillance.
Since 2000, hospitalized cases of EV infections in France
have been voluntarily reported through a laboratory network
to the national Institute for Public Health. We compared the
epidemiological data from the local sentinel surveillance sys-
tem with those collected at a national level.
Enterovirus detection and genotyping
Viral RNA was extracted from 200 lL of the universal viral
transport medium on the NucliSens EasyMAG automated
system (bioMe´rieux, Marcy l’Etoile, France). The EV genome
was detected by real-time NASBA detection using the Nucli-
Sens EasyQ Enterovirus kit (bioMe´rieux). Using the same
RNA extracts, genotyping of EV strains was performed with
a procedure similar to that described previously for the iden-
tiﬁcation of HEVB serotypes [20]. After cDNA synthesis, the
complete 1D gene sequence encoding the VP1 capsid protein
was ampliﬁed with a semi-nested PCR (1D PCR assay), using
primers developed speciﬁcally for HEVA serotypes [18]. We
performed a second PCR assay targeting the genome seg-
ment 1A/1B comprising the VP4 and partial VP2 (5¢ end)
encoding genes if the 1D PCR assay was negative [20]. Visi-
ble PCR products after gel electrophoresis were puriﬁed and
subjected to nucleotide sequencing as described earlier [20].
The sequences determined in the study (n = 117) were sub-
mitted to the EMBL/DDBJ/GenBank databases (accession
nos. HE572901 to HE573016).
Viral culture
Each specimen underwent at least two passages in human
rhabdomyosarcoma (RD) and human lung embryonic ﬁbro-
blast (MRC5) cell lines. The appearance of viral cytopathic
effects was investigated by indirect immunological methods
for adenovirus (Ridaquick Rotavirus/Adenovirus Comb,
r-Biopharm, Darmstadt, Germany), herpes simplex types 1
(HSV1) and 2 (HSV2) (Imagen Herpes simplex virus type 1
and 2; Oxoid, Hants, UK) and cytomegalovirus (monoclonal
anti-cytomegalovirus immediate early antigen, Arge`ne, Verni-
olle, France). The supernatants of cell cultures exhibiting an
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EV-like cytopathic effect were collected and stored at
)20C.
Identiﬁcation of EV serotypes and phylogenetic analyses
Genotyping was carried out by BLAST analysis of 1D
sequences with a database of reference sequences and was
conﬁrmed by phylogenetic comparison with the EV proto-
type strains. The nucleotide sequences of strains assigned to
serotypes CV-A6, CV-A10, and EV-71 were compared with
homologous sequences available in GenBank (up to 27 June
2011), to identify intratypic variants and investigate phyloge-
netic relationships with strains circulating in distant geo-
graphical areas. Multiple sequence alignments were
constructed using CLUSTALW implemented in the BIOEDIT pro-
gram. Phylogenetic trees were constructed by the neigh-
bour-joining method. Genetic distances were calculated with
the Tamura–Nei model of sequence evolution using MEGA 5
software [21].
Statistical analyses
Data were analysed using SAS statistical software (Version
9.1.3, SAS Institute, Cary, NC, USA). The statistical differ-
ences between proportions were tested by chi-squared test
or Fisher’s exact test. Analysis of variance was used to com-
pare means of age. A P-value <0.05 was regarded as statisti-
cally signiﬁcant.
Results
Epidemiological data
From April to December 2010, 222 children (mean age
2.4 years; range 5 weeks–14 years) presenting with HFMD/
HA and/or gingivostomatitis had specimens submitted by the
sentinel physicians for EV testing. Most of the children (201/
222, 90.5%) were seen by private sector paediatricians, who
reported an upsurge in these clinical presentations in com-
parison with earlier years. Infection with EV was diagnosed
in 143 (64.4%) children by EV genome detection in throat
(n = 95) or buccal (n = 48) swab specimens. An EV strain
was isolated in 130 (90.9%) of the 143 EV-positive speci-
mens; RD cells were the only permissive cell line for 73%
(95/130). The EV infections mainly occurred between May
and July (77%, 111/143) and peaked in June. A second minor
wave of EV infections was observed between October and
December (Fig. 1).
Demographic and clinical features of patients with EV
versus non-EV infections
Testing for EV was negative in 79 patients, and in 25 (31.6%)
of these another pathogen was isolated in cell culture. Eigh-
teen children presented with HSV1 infection associated with
gingivostomatitis alone (n = 8, 47%) or in association with
HFMD (n = 2), HA (n = 3) or both (n = 2). Two patients
presented with HA alone. No clinical data was available for
one patient. The other identiﬁed viruses were cytomegalovi-
rus (CMV, n = 3), rhinovirus (n = 3) and adenovirus (n = 1).
Co-infection with EV was diagnosed in three children with
HSV1 (n = 1) or CMV (n = 2).
HFMD was only observed in 63/222 patients (28.4%). HA
was the predominant clinical presentation (63.8%, 139/222
cases) and was frequently associated with clinical signs of
HFMD (67/139, 48%). The mean age of EV-infected patients
was lower than that of non-EV-infected patients (p 0.048)
(Table 1). The number of males was signiﬁcantly higher
among patients presenting with EV infection (p 0.0009). Most
children in both groups had fever. HFMD (p 0.006) or a
vesicular rash on hands, feet, knees or buttocks without
oral ulcers (p 0.0002) was signiﬁcantly more frequently
observed in EV infections than in non-EV infections.
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FIG. 1. Distribution of the number of
enterovirus-positive specimens and pre-
valent serotypes by month between
April and December 2010. CV-A, cox-
sackievirus A; EV, enterovirus; HEVB,
human enterovirus B species.
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HA alone (p 0.0051), oral ulcers and gingivostomatitis
alone (p <0.0001) were signiﬁcantly more frequent in
non-EV-infected patients. For the other reported clinical
signs, differences were not statistically signiﬁcant.
Children with HFMD and HA were distributed throughout
the city. Environmental data were obtained in 127/222 chil-
dren (57.2%). Interestingly, 42 (33.1%) children had contact
with household members or day-nursery playmates who pre-
sented similar symptoms. No statistically signiﬁcant difference
was found between EV-infected and non-EV-infected chil-
dren, nor between different child-care arrangements (child-
minder, public preschool, school or home).
Prevalent serotypes and clinical presentations
A deﬁnite serotype was identiﬁed in 141/143 (98.6%)
patients with proven EV infection (Fig. 2). Of the 141 EV
strains, 134 (95%) were assigned to a serotype within the
HEVA species. The most predominant EVs were CV-A10
(39.9%) and CV-A6 (28%). CV-A16 and EV-71 accounted for
17.5% and 6.3% of cases, respectively, and other HEVA sero-
types (CV-A4 and CV-A8) represented 2.1%. HEVB sero-
types (echovirus 9, n = 2; CV-A9, CV-B4 and CVB-5, and
echoviruses 16 and 17, n = 1 each) were also identiﬁed in
5.6% of cases. Serotype distribution differed between the
summer and winter waves of EV infections. Serotypes CV-
TABLE 1. Demographic and clinical features of patients with enterovirus (EV) infections versus non-EV infections
All patientsa (n = 218) Enterovirus negativea (n = 75) Enterovirus positive (n = 143) p value
Mean age at enrolment, years 2.4 2.8 2.2 0.048
Male/female ratio 1.02 0.55 1.42 0.0009
Fever (temperature >38C) 167 (76.6) 52 (69.3) 115 (80.4) 0.07
Hand, foot and mouth disease 63 (28.9) 13 (17.3) 50 (35) 0.006
Oral ulcers alone 26 (11.9) 20 (41.7) 6 (9.4) <0.0001
Vesicular rash on hands, feet, knees or buttocks without oral ulcers 53 (24.3) 7 (9.3) 46 (32.2) 0.0002
Gingivostomatitis 43 (19.7) 21 (28) 22 (15.4) 0.0262
Alone 15 (6.9) 13 (17.3) 2 (1.4) <0.0001
Herpangina 139 (63.8) 44 (58.7) 95 (66.4) 0.2571
Alone 72 (33) 34 (45.3) 38 (26.6) 0.0051
Digestive signs (abdominal pain, diarrhoea) 30 (13.8) 15 (20) 15 (10.5) 0.053
Ear, nose and throat signs 15 (6.9) 4 (5.3) 11 (7.7) 0.51
Respiratory signs 5 (2.3) 2 (2.7) 3 (2.10) 1
Data are n (%) of patients, unless otherwise indicated.
awith available clinical data.
Enterovirus positive 
specimens
n =143
Identification in clinical
samples
1D sequence
n = 107/143 (74.8%)
Yes
1A/1B sequence
n = 36 (25.2%)
No
n = 22/36 (61.1%)
CV-A16, n =10; HEVB, n = 7; 
CV-A10, n = 3; CV-A4, n = 2
Yes
Identification from EV 
isolates
No
1D sequence
n = 14
n = 10/14
CV-A16, n = 8;                         
CV-A6, n =1; CV-A10, n = 1
Yes
1A/1B sequence
n = 4
No
n = 2/4
CV-A16, n = 1; CV-A6, n = 1
Yes
FIG. 2. Methodological approach and results of enterovirus (EV) genotyping. Prospective EV genotyping was attempted in the 143 consecutive
patients with EV-positive specimens with the same extract used for the EV genome detection assay. Identiﬁcation was performed from the com-
plete 1D sequence for 107 (74.8%) specimens and from partial 1A–1B sequence for 22 of the 36 remaining samples. For 12 patients, EV identiﬁ-
cation was obtained with the strains isolated in cell culture by genotyping of the complete 1D sequence (n = 10) or partial 1A–1B sequence
(n = 2). CV, coxsackievirus; HEVB, human enterovirus B species.
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A10 (57/119, 47.9%) and CV-A6 (40/119, 33.6%) predomi-
nated from April to July, whereas CV-A16 was involved in
66.7% (16/24) of the EV infections during the second half of
the study (Fig. 1). Table 2 compares the demographic and
clinical data of patients between the four most prevalent ser-
otypes. HA was more frequent in patients with CV-A6 and
CV-A10 infections. Infections with CV-A16 strains were pre-
dominantly responsible for strictly deﬁned HFMD and were
less frequently associated with fever.
Phylogenetic investigations
Phylogenetic analysis of viral sequences showed that the EV-
71 strains belonged to genotype C2 (data not shown). On
the basis of analysis of partial 1D sequences, CV-A10 strains
were divided into two clusters (18.6% nucleotide differences)
(Fig. 3a). Most virus strains belonged to cluster A (mean
nucleotide identity of 97.9%) and were closely related to
strains isolated during the 2008 HFMD outbreak in Finland.
Only one strain (CF203060_FRA10) belonged to cluster B
and grouped together with strains isolated in Slovakia (2007)
and China (2008–2010). Two genetic groups were detected
among the CV-A6 strains (Fig. 3b). Most of the strains were
included in cluster A (99.6% nucleotide identity) and dis-
played close relationships with viruses recovered during the
2008 Finnish outbreak. A number of strains belonged to clus-
ter B (97.2% nucleotide identity), which also included viruses
of various geographical origins.
Discussion
The HFMD/HA cases reported here were investigated for
the ﬁrst time in a European country through a prospective
observational study involving a sentinel surveillance system
composed of practitioners in the private and public sec-
tors. Studies in Europe have focused mainly on EV-infected
patients admitted to hospital and so there is scant infor-
mation on the epidemiology of HFMD/HA cases. For this
reason we could not have predicted the large scale of the
outbreak before starting the study. It allowed the real-time
detection of a dual outbreak caused by CV-A6 and CV-
A10 infections, the third in the period 2008–2010 in Eur-
ope.
During the 9 months of the survey study, 143/222 (64.4%)
children presented with an EV infection. The diagnosis of EV
infection was established from throat or buccal swab speci-
mens. Taking vesicular ﬂuid specimens in young children
might have been considered too invasive by the children’s
parents, and was considered difﬁcult to perform by the pae-
diatricians in the private sector. Compared with diagnosis
made on the basis of vesicular ﬂuid specimens, we may have
underestimated the number of EV infections or identiﬁed an
EV different from the real aetiological agent of HFMD,
because EVs can remain present in the throat for several
weeks after an infection. Clinical signs of HFMD and HA
were observed in 96/143 and 95/143 children (67.7% and
66.4%), respectively, and were frequently associated. Geno-
typing of EV was performed directly in clinical specimens for
90.2% of the patients. Using generic primers designed for the
ampliﬁcation of a partial 1D sequence [22], EV identiﬁcation
was effective for 55% of the EV-positive clinical samples dur-
ing the 2008 Finnish outbreak [10]. The RT-PCR assay used
in our study proved to be useful for identifying four other
HEVA serotypes in addition to EV-71 [18] and provided an
accurate picture of the epidemiology of HEVA. Only a few
other RT-PCR assays used for genotyping have been
TABLE 2. Demographic and clinical features associated with the different enterovirus serotypes
Enterovirus serotypes
Coxsackievirus A10
(n = 57)
Coxsackievirus A6
(n = 40)
Coxsackievirus A16
(n = 25)
Enterovirus 71
(n = 9) p valuea
Mean age at enrolment, years 2.1 ± 1.3 2.0 ± 1.0 2.7 ± 1.3 2.1 ± 1.3 0.1371
Male/female ratio 1.03 3 1.08 3.5 0.0552
Fever (temperature >38C) 52 (91.2) 33 (82.5) 13 (52) 7 (77.8) 0.0007
Hand, foot and mouth disease 16 (28.1) 12 (30) 18 (72) 3 (33.3) 0.0012
Oral ulcers alone 2 (8.7) 0 0 3 (50) 0.0023
Vesicular rash on hands, feet,
knees or buttocks without oral ulcers
14 (24.6) 20 (50) 6 (24) 2 (22.2) 0.0363
Gingivostomatitis 11 (19.3) 4 (10) 6 (24) 1 (11.1) 0.4288
Herpangina 44 (77.2) 28 (70) 12 (48) 3 (33.3) 0.0097
Alone 24 (42.1) 7 (17.5) 1 (4) 0 0.0002
Digestive signs (abdominal pain, diarrhoea) 6 (10.5) 3 (7.5) 1 (4) 2 (22.2) 0.3685
Ear, nose and throat signs 4 (7) 3 (7.5) 1 (4) 0 1
Respiratory signs 0 0 1 (4) 0 0.2595
Data are mean ± standard deviation for age and n (%) of patients for clinical symptoms.
aSigniﬁcant variations between the four groups (CV-A10, CV-6, V-A16 and EV71) were evaluated using analysis of variance for age, and chi-squared test or Fisher’s exact test
for clinical symptoms.
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reported to identify HEVA serotypes from clinical samples
[22,23]. In most epidemiological studies of HFMD/HA, EV
genotyping relies on virus isolates [3,4] despite the difﬁculty
of growing HEVA serotypes in cell culture [24].
CV-A10 and CV-A6 accounted for two-thirds of all infec-
tions in the outbreak. The occurrence of infections with
these two serotypes was similar to the epidemiological pat-
tern observed 2 years earlier during a nationwide HFMD
 AY421764__CA6_Gdula
95
78
98
88
94
96
83
78
78
84
0.05
Cluster A
Finland 2008
France 2010
Cluster B
Finland 2008
France 2010
Japan 2000
Japan 2000
Finland 2002–2004
Japan 1999–2003
Japan 1996
Finland 2008 
Sweden 2005         
China 2004
 China 2004–2008
 Japan 2000–2001
 Japan 2003
 China 2009–2010
 China 2009
 AY421767_CA10_Kowalik
10081
76
91
97
88
91
85
95
91
100
84
79
89
97
76
0.05
Cluster A
Finland 2008
France 2010
Japan 2003
China 2008 
USA
Russia 2001       
Slovakia 2002
Japan 2003      
Slovakia 2007         
China 2009–2010     
France 2010
Cluster B 
(a) (b)
FIG. 3. Phylogenetic trees based on partial VP1 coding sequence of (a) coxsackievirus A10 (246 nucleotides) and (b) coxsackievirus A6 (293 nu-
cleotides). Genetic distances were calculated with the Tamura–Nei model of evolution. The tree was constructed by the neighbour-joining
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outbreak in Finland [10] and Spain [25]. Of the 1175 EV
infections reported to the French Institute for Public Health
in 2010, 42 cases were associated with clinical signs of
HFMD/HA, of which 59% occurred in south-eastern France.
The number of HFMD/HA cases in 2010 was up to ten-fold
higher than the yearly number of cases reported during the
period 2005–2009. These data indicate a recent increase in
the overall circulation of HEVA serotypes. The seasonal pat-
terns of HFMD/HA cases were similar in the national
records and during the sentinel study but serotype distribu-
tion indicated a higher nationwide prevalence of CV-A16 in
the summer months. Comparisons of the clinical presenta-
tions associated with CV-A6 and CV-A10 in the three Euro-
pean outbreaks are hampered by differences in study designs
as both the Finnish and Spanish studies were retrospective
and focused on HFMD cases [10,25]. When surveillance is
based on sentinel systems with a priori distinct clinical deﬁni-
tions for HFMD and HA, observational studies, from Taiwan
[4] and Japan [26], showed that CV-A6 and CV-A10 were
associated with HA, whereas CV-A16 and EV-71 were
involved in HFMD cases. In addition, as described for earlier
outbreaks in Asian countries [4,26], the community outbreak
in France occurred in two waves with most cases being diag-
nosed from April to July. Whatever the EV serotype
involved, none of the patients presented with severe or neu-
rological symptoms whereas neurological manifestations
(encephalitis and convulsions) were reported in ﬁve cases
during the Finnish outbreak [10]. At the national level in
France, 12 infections with CV-A6 and CV-A10 were
reported to the National Institute of Health among children
hospitalized during 2010. Only one boy, aged 11 months,
presented with convulsions and had a CV-A6 infection. Dur-
ing the same period, 25 EV-71 infections were reported
nationally: of the patients with clinical data available (n = 22),
eight (36.4%) presented with meningitis. Onychomadesis was
a hallmark of earlier HFMD outbreaks in Europe [10,25].
This manifestation was not observed during our study.
Although the information was given to the sentinel paediatri-
cians soon after the ﬁrst identiﬁcation of CV-A6 and CV-
A10 strains, we cannot exclude the possibility that parents
did not inform the physicians of the occurrence of nail
abnormalities in their children. Considering the close genetic
relationships between all CV-A6 and CV-A10 strains recov-
ered in Europe, these clinical differences remain unclear.
The report of three consecutive outbreaks of dual CV-A6
and CV-A10 infections in distinct European countries over
the years 2008–2010 is consistent with an epidemiological
pattern of emerging virus variants spreading into new geo-
graphical areas. CV-A10 was predominant in 2004, 2007 and
2009 in Taiwan [4,9] and in Japan in 2007 [27], and CV-A6
was the most frequent serotype in Japan in 2005 [26] and in
Singapore in 2008 [28]. In Europe, a high prevalence of CV-
A6 or CVA-10 infections was only reported in Norway [29]
and Germany [30] before 2003. In our study, phylogenetic
analysis of CV-A10 sequences showed that the predominant
lineage in circulation is a genetic variant distinct from that
detected over the same period in China or earlier in Europe.
Similarly, cluster A CV-A6 viruses constitute a distinct Euro-
pean lineage. This geographical clustering pattern is reminis-
cent of that seen with EV-71 strains isolated after 2006 in
Europe [14,18]. Spreading of genetic variants possibly origi-
nating from Asian countries may explain the occurrence of
outbreaks in Europe but the factors associated with an
apparent dual spreading of both viruses remain unknown.
Phylogenetic analysis of the complete 1D sequence will be
needed to establish robust genetic relationships between
strains from the two geographical areas.
The occurrence of three successive outbreaks over
3 years indicates that HFMD and HA are not rare in Europe.
Whether this is a result of an increasing circulation of HEVA
serotypes or of improved surveillance needs investigations
over longer periods. The overall epidemiology of HFMD/HA
caused by HEVA serotypes in European countries resembles
that observed in Asian countries, but the lower frequency of
EV-71 epidemics in Europe remains unexplained. As there is
endemic circulation of EV-71 genogroups C1 and C2 in Eur-
ope, prospective diagnosis and collection of clinical data
combined with genotyping yield consistent epidemiological
data and should be considered for the management of future
national outbreaks.
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